Safety, immunogenicity, and efficacy of NDV-3A against Staphylococcus aureus colonization: A phase 2 vaccine trial among US Army Infantry trainees-Reference-Cited by-同舟云学术

Safety, immunogenicity, and efficacy of NDV-3A against Staphylococcus aureus colonization: A phase 2 vaccine trial among US Army Infantry trainees

Published:2021-05 Issue:23 Volume:39 Page:3179-3188
ISSN:0264-410X
Container-title:Vaccine
language:en
Short-container-title:Vaccine

Author:

Millar Eugene V.,Bennett Jason W.,Barin Burc,Carey Patrick M.,Law Natasha N.,English Caroline E.,Schwartz Michael M.,Cochrane Terrence,Ellis Michael W.,Tribble David R.,Timothy Cooke M.,Hennessey John P.

Funder

National Institute of Allergy and Infectious Diseases

Defense Health Agency Consortium

Publisher

Elsevier BV

Subject

Infectious Diseases,Public Health, Environmental and Occupational Health,General Veterinary,General Immunology and Microbiology,Molecular Medicine

Reference33 articles.

1. Where does a Staphylococcus aureus vaccine stand?;Fowler;Clin Microbiol Infect,2014

2. A serologic correlate of protective immunity against community-onset Staphylococcus aureus infection;Fritz;Clin Infect Dis,2013

3. The Fall of a Dogma? Unexpected High T-Cell Memory Response to Staphylococcus aureus in Humans;Kolata;J Infect Dis,2015

4. Th1-Th17 cells mediate protective adaptive immunity against Staphylococcus aureus and Candida albicans infection in mice;Lin;PLoS Pathog,2009

5. Molecular explanation for the contradiction between systemic Th17 defect and localized bacterial infection in hyper-IgE syndrome;Minegishi;J Exp Med,2009

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Vaccines and monoclonal antibodies to prevent healthcare-associated bacterial infections;Clinical Microbiology Reviews;2024-09-12

2. Reverse development of vaccines against antimicrobial-resistant pathogens;npj Vaccines;2024-04-03

3. Anti-Staphylococcus aureus potential of compounds from Ganoderma sp.: A comprehensive molecular docking and simulation approaches;Heliyon;2024-04

4. Profiling of serum factors associated with Staphylococcus aureus skin and soft tissue infections as a foundation for biomarker identification;Frontiers in Immunology;2023-11-20

5. Efficacy of a 4-Antigen Staphylococcus aureus Vaccine in Spinal Surgery: The STaphylococcus aureus suRgical Inpatient Vaccine Efficacy (STRIVE) Randomized Clinical Trial;Clinical Infectious Diseases;2023-05-01